A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease

New England Journal of Medicine

Volumn 331, Issue 8, 1994, Pages 489-495

  Serruys, Patrick W ^a   de Jaegere, Peter ^a   Kiemeneij, Ferdinand ^b   Macaya, Carlos ^c   Rutsch, Wolfgang ^d   Heyndrickx, Guy ^e   Emanuelsson, Hakan ^f   Marco, Jean ^g   Legrand, Victor ^h   Materne, Pierre ⁱ   Belardi, Jorge ^j   Sigwart, Ulrich ^k   Colombo, Antonio ^l   Goy, Jean Jacques ^m   Van Den Heuvel, Paul ⁿ   Delcan, Juan ^o   Morel, Marie Angele ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e Onze Lieve Vrouw Ziekenhuis   (Belgium)

^f SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^g CLINIQUE PASTEUR   (France)

^h UNIVERSITY OF LIÈGE   (Belgium)

ⁱ Centre Hospitalier Regional de La Citadelle   (Belgium)

^j INSTITUTO CARDIOVASCULAR DE BUENOS AIRES   (Argentina)

^k NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^l EMO GVM CENTRO CUORE COLUMBUS   (Italy)

^m LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

ⁿ MIDDELHEIM HOSPITAL   (Belgium)

^o HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEATH; FEMALE; FOLLOW UP; HEART INFARCTION; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STENT;

ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CONFIDENCE INTERVALS; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; REOPERATION; RISK; STENTS; THROMBOLYTIC THERAPY; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 0028123099     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199408253310801     Document Type: Article

References (26)

1. Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 1987; 316: 701-706
2. Roubin GS, Cannon AD, Agrawal SK, Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty. Circulation 1992; 85: 916-927
3. de Jaegere PPT, Hermans WR, Rensing BJ, Strauss BH, de Feyter PJ, Serruys PW Matching based on quantitative coronary angioplasty as a surrogate for randomized studies: comparison between stent implantation and balloon angioplasty of native coronary artery lesions. Am Heart J 1993; 125: 310-319
4. Fischman DL, Savage MP, Ellis SG, et al. Restenosis after Palmaz-Schatz stent implantation. In: Serruys PW, Strauss BH, King SB III, eds. Restenosis after intervention with new mechanical devices. Vol. 131 of Developments in cardiovascular medicine. Dordrecht, the Netherlands: Kluwer Academic, 1992:191-205.
5. Schatz RA, Baim DS, Leon M, Clinical experience with the Palmaz-Schatz coronary stent: initial results of a multicenter study. Circulation 1991; 83: 148-161
6. Serruys PW, Strauss BH, Beatt KJ, Angiographic follow-up after placement of a self-expanding coronary-artery stent. N Engl J Med 1991; 324: 13-17
7. de Jaegere PPT, de Feyter PJ, van der Giessen WJ, Serruys PW Endovascular stents: preliminary clinical results and future developments. Clin Cardiol 1993; 16: 369-378
8. Serruys PW, Foley DP, de Feyter PJ, eds. Quantitative coronary angiography in clinical practice. Dordrecht, the Netherlands: Kluwer Academic, 1994.
9. Blackburn H, Keys A, Simonson E, Rautaharju P, Punsar S The electrocardiogram in population studies: a classification system. Circulation 1960; 21: 1160-1175
10. The TIMI Study Group. The thrombolysis in myocardial infarction (TIMI) trial: Phase 1 findings. N Engl J Med 1985; 312: 932-936
11. Pocock SJ Interim analyses for randomized clinical trials: the group sequential approach. Biometrics 1982; 38: 153-162
12. Greenland S, Robins JM Estimation of a common effect parameter from sparse follow-up data. Biometrics 1985; 41: 55-68
13. Hermans WRM, Rensing BJ, Foley DP, Therapeutic dissection after successful coronary balloon angioplasty: no influence on restenosis or on clinical outcome in 693 patients. J Am Coll Cardiol 1992; 20: 767-780
14. Ambrose JA, Winters SL, Stern A, Angiographic morphology and the pathogenesis of unstable angina pectoris. J Am Coll Cardiol 1985; 5: 609-616
15. Ellis SG, Roubin GS, King SB III, Douglas JS Jr, Cox WR Importance of stenosis morphology in the estimation of restenosis risk after elective percutaneous transluminal coronary angioplasty. Am J Cardiol 1989; 63: 30-34
16. Dorros G, Cowley MJ, Simpson J, Percutaneous transluminal coronary angioplasty: report of complications from the National Heart, Lung, and Blood Institute PTCA Registry. Circulation 1983; 67: 723-730
17. de Jaegere P, de Feyter P, Serruys PW Intracoronary stenting. Curr Rev Interv Cardiol 1993; 8: 1-17
18. Cohen DJ, Breall JA, Ho KK, Economics of elective coronary revascularization: comparison of costs and charges for conventional angioplasty, directional atherectomy, stenting and bypass surgery. J Am Coll Cardiol 1993; 22: 1052-1059
19. Cohen DJ, Breall JA, Ho KK, Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease: use of a decision-analytic model. Circulation 1994; 89: 1859-1874
20. Hirshfeld JW, Schwartz SS, Jugo R, Restenosis after coronary angioplasty: a multivariate statistical model to relate lesion and procedure variables to restenosis. J Am Coll Cardiol 1991; 18: 647-656
21. Ellis SG, Roubin GS, Wilentz J, Douglas JS Jr, King SB III Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart J 1989; 117: 777-782
22. Perin EC, Turner SA, Ferguson JJ Relationship between the response to heparin and restenosis following PTCA. Circulation 1990; 82: Suppl III: III-497 abstract.
23. Faxon D, Spiro T, Minor S, Enoxaparin, a low molecular weight heparin, in the prevention of restenosis after angioplasty: result of a double blind randomized trial. J Am Coll Cardiol 1992; 19: Suppl A: 258A-258A abstract.
24. Thornton MA, Gruentzig AR, Hollman J, King SB III, Douglas JS Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study. Circulation 1984; 69: 721-727
25. Urban P, Buller N, Fox K, Shapiro L, Bayliss J, Rickards A Lack of effect of warfarin on the restenosis rate or on clinical outcome after balloon coronary angioplasty. Br Heart J 1988; 60: 485-488
26. Rensing BJ, Hermans WR, Beatt KJ, Quantitative angiographic assessment of elastic recoil after percutaneous transluminal coronary angioplasty. Am J Cardiol 1990; 66: 1039-1044